Market open
RenovoRx/$RNXT
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About RenovoRx
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.
Ticker
$RNXT
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
10
ISIN
US75989R1077
Website
RenovoRx Metrics
BasicAdvanced
$43M
-
-$0.39
-
-
Price and volume
Market cap
$43M
52-week high
$1.21
52-week low
$0.75
Average daily volume
133K
Financial strength
Current ratio
9.07
Quick ratio
8.539
Long term debt to equity
1.414
Total debt to equity
1.414
Management effectiveness
Return on assets (TTM)
-69.73%
Return on equity (TTM)
-136.13%
Valuation
Price to revenue (TTM)
129.727
Price to book
3.28
Price to tangible book (TTM)
3.28
Price to free cash flow (TTM)
-3.018
Growth
Earnings per share change (TTM)
-43.11%
3-year earnings per share growth (CAGR)
-30.97%
RenovoRx News
AllArticlesVideos
RenovoRx, Inc. (RNXT) Q1 2025 Earnings Conference Call Transcript
Seeking Alpha·4 days ago
RenovoRx Reports First Quarter 2025 Financial Results and Business Highlights
Business Wire·4 days ago
RenovoRx to Participate in Fireside Chat at A.G.P. Virtual Healthcare Company Showcase on May 21st
Business Wire·5 days ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for RenovoRx stock?
RenovoRx (RNXT) has a market cap of $43M as of May 19, 2025.
What is the P/E ratio for RenovoRx stock?
The price to earnings (P/E) ratio for RenovoRx (RNXT) stock is 0 as of May 19, 2025.
Does RenovoRx stock pay dividends?
No, RenovoRx (RNXT) stock does not pay dividends to its shareholders as of May 19, 2025.
When is the next RenovoRx dividend payment date?
RenovoRx (RNXT) stock does not pay dividends to its shareholders.
What is the beta indicator for RenovoRx?
RenovoRx (RNXT) does not currently have a Beta indicator.